GH
MRNA icon

GAM Holding’s Moderna MRNA Stock Holding History

GAM Holding’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$276K – 302
2025
Q2 		$276K Buy
+10,000
New +$263K 0.02% 221
2024
Q4 		– Sell
-5,129
Closed -$343K – 183
2024
Q3 		$343K Sell
5,129
-43
-0.8% -$3.95K 0.03% 146
2024
Q2 		$614K Sell
5,172
-14
-0.3% -$1.77K 0.05% 143
2024
Q1 		$553K Sell
5,186
-520
-9% -$52.4K 0.04% 149
2023
Q4 		$567K Hold
5,706
– – 0.04% 149
2023
Q3 		$589K Buy
5,706
+3
+0.1% +$335 0.04% 159
2023
Q2 		$693K Buy
5,703
+923
+19% +$123K 0.05% 171
2023
Q1 		$734K Buy
4,780
+53
+1% +$8.74K 0.05% 178
2022
Q4 		$849K Buy
4,727
+441
+10% +$72.1K 0.07% 177
2022
Q3 		$507K Buy
4,286
+3
+0.1% +$455 0.04% 188
2022
Q2 		$612K Buy
4,283
+2,109
+97% +$301K 0.04% 203
2022
Q1 		$375K Sell
2,174
-153
-7% -$25.8K 0.02% 240
2021
Q4 		$591K Buy
+2,327
New +$680K 0.03% 229

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GAM Holding's MRNA Position: Q3 2025 in Review

GAM Holding sold out of Moderna (MRNA) in Q3 2025, closing a stake of 10,000 shares — an estimated $276K sold.

GAM Holding first reported a position in MRNA in Q4 2021 and held it in 13 quarters. The position peaked at $849K in Q4 2022. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • GAM Holding reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • GAM Holding sold 10,000 Moderna shares in Q3 2025, an estimated $276K.
  • GAM Holding first reported a position in Moderna in Q4 2021 and held it in 13 quarters.
  • GAM Holding's Moderna position peaked at $849K in Q4 2022.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on GAM Holding's 13F filing for Q3 2025, filed 21 Oct 2025.